iShares IV - iShares NASDAQ US Biotechnology UCITS ETF Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

What is the ownership structure of OM3E?
Owner Type	Number of Shares	Ownership Percentage
Institutions	3,781,769	100%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 17 shareholders own 0% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
0%	Hamburger Sparkasse AG, Asset Management Arm	1,180,000	€0	0%	2.08%
0%	Capitell VermÖGens-Management Ag	825,000	€0	0%	0.75%
0%	Andbank Wealth Management SGIIC S.A.U., Asset Management Arm	618,855	€0	0%	0.98%
0%	Generali Investments, druzba za upravljanje, d.o.o.	560,784	€0	0%	0.49%
0%	Rockbridge TFI S.A.	80,179	€0	0%	0.5%
0%	Bellatrix Asset Management S.A.	80,000	€0	0%	0.19%
0%	Ringelstein & Partner Vermoegensbetreuungs GmbH	70,000	€0	-36.4%	0.47%
0%	Entrepreneur Partners AG, Asset Management Arm	66,800	€0	0%	0.1%
0%	Lombard Odier Darier Hentsch & Cie Asset Management	53,000	€0	0%	no data
0%	Spirit Asset Management SA	50,000	€0	0%	0.32%
0%	Fundatis Investment Management GmbH	48,000	€0	0%	16.21%
0%	Olympia Wealth Management Ltd	40,000	€0	0%	0.47%
0%	IFM Independent Fund Management AG	37,000	€0	0%	0.22%
0%	Deka VermÖGensmanagement Gmbh	36,641	€0	0%	0.01%
0%	Vig/CQuadrat Towarzystwo Funduszy Inwestycyjnych SA	31,710	€0	7.09%	1.51%
0%	AXA Towarzystwo Funduszy Inwestycyjnych SA	3,700	€0	0%	0.01%
0%	Deka Investment GmbH	100	€0	0%	no data